Using this discovery set of high-confidence RB1-proficient and RB1-defective samples, a subsampling-driven robust differential mRNA abundance analysis was performed between these two groups resulting in an RBness signature (RBNSig) of breast cancer (BC) (fig. This evidence concerns the gene RB1 and breast carcinoma.